Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48. - Asselah T; Lampertico P; Aleman S; Bourlière M; Streinu-Cercel A; Bogomolov P; Morozov V; Stepanova T; Lazar S; Manuilov D; Mercier RC; Tseng S; et al. (Liver international : official journal of the International Association for the Study of the Liver, 2025)